T-DXd and Dato-DXd are now approved treatments in Japan for patients with breast cancer.
|Articles|August 1, 2016
Leukemia Incidence in the United States in 2016
Author(s)Cancer Network Editors
Do you know the yearly incidence of each type of leukemia? How about the rate of leukemia in children and adolescents?
Advertisement
Question 1
The correct answer is:
C. 6,590
Question 2
The correct answer is:
C. 19,950
Question 3
The correct answer is:
B. 4.8
Question 4
The correct answer is:
A. 4,610 and 3,610
Question 5
The correct answer is:
D. 60,140
Advertisement
Related to this article
Data from the phase 3 EMBER-3 trial support the full approval of imlunestrant plus abemaciclib in this breast cancer population.
!["Patients [with cancer] and physicians would rather have a fixed-duration treatment, if possible," said Julie M. Vose, MD, MBA, at SOHO 2026.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/1cfb57db416943d8f8690afb0bc0d13aa3d90683-400x400.jpg?w=350&fit=crop&auto=format)
"Patients [with cancer] and physicians would rather have a fixed-duration treatment, if possible," said Julie M. Vose, MD, MBA, at SOHO 2026.
Updated NCCN Guidelines for multiple myeloma add a dedicated MRD testing framework and expand recommended MRD assessment timepoints.
The European Medicines Agency’s CHMP recommended approval of relacorilant plus nab-paclitaxel for platinum-resistant ovarian cancer based on the ROSELLA trial.
Posters highlighted sex-based differences in aggressive B-cell NHL, third-line therapies in aggressive BCL, and real-world safety with CD20/CD3 bispecifics.
NICE recommended trastuzumab deruxtecan for reimbursement in England for HER2-low metastatic breast cancer, backed by DESTINY-Breast04 data.
Subcutaneous amivantamab is safer and more convenient for patients compared with the intravenous formulation, according to Misako Nagasaka, MD, PhD.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears Triton Robotic Endoscopy System for Colon Procedures
2
FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer
3
ASTRO Issues First Clinical Practice Guideline on Radiation for Bladder Cancer
4
KST-6051 Receives FDA Fast Track Designation in KRAS-Mutant Solid Tumors
5